Paul-Ehrlich-Gesellschaft | Impressum | Datenschutz | Kontakt
Mitgliederlogin:


heute ist der 16.12.2018  letzte Änderung am 12.12.2018 

Aktuelles

26th International Congress of Chemotherapy and Infection, 18.-21. Juni, Toronto

Scientific Programme (Symposia) at a Glance

http://www.icc-09.com/

Thursday 18th  June, 2009, 8:30-10:00
Antibiotic Usage in Animal Agriculture and its Interface with Human Medicine
Challenges in Antimicrobial Dosing and Delivery
Complicated /Nosocomial Urinary Tract Infections in Urology
Antimicrobial Resistance: Main Threats and Hopes
Advances in Influenza Vaccination

Thursday 18th  June, 2009, 10:45-12:45
CAP/HAP/VAP - Challenges and Controversies in Pneumonia
New Concepts in Antimicrobial Resistance
UTI in Special Patient Groups
Liver Failure Caused by Severe Hepatitis
Infectious Diseases in Catastrophic Areas

Thursday 18th June, 2009, 13:15-15:15
MRSA: Challenges in 2009
Tuberculosis: New Strategies for an Old Disease
Virology of Hepatitis Viruses for Clinicians
Present and Future Strategies for Clonal Spread of Drug-Resistant Microbes
Problems and Progress in the Diagnosis and Treatment of Invasive Fungal Infections

Thursday 18th June, 2009, 15:30-17:30
Hitting Hard & Fast: Role of High-Dose Fluoroquinolone Regimens in RTI

Thursday 18th June, 2009, 17:30-19:00
The emergence of H1N1 Influenza A virus
Co-sponsored by the Public Health Agency of Canada

Thursday 18th June, 2009, 19:00-19:45: Special Lecture
Climate Change - Health Impacts, Responsibilities and Action: Health in a Warmer World
Kirsty Duncan (Toronto, Canada)

Thursday 18th June, 2009, 20:00-21:00
Opening Reception and Welcome Addresses

Friday 19th June, 2009, 07:15-08:15: Meet the Expert Sessions
Urinary Tract Infection - What is Next?
Fungal Infections in ICU - The Great Challenge
Antiviral Resistance in Influenza: Clinical and Public Health Consequences
Traveler’s Health Issues – Pre- and Post-Travel
The Problem with Glycopeptides

Friday 19th June, 2009, 08:30-10:00
Emerging Issues in HIV Medicine
Preventing Infection in Patients Receiving Exogenous Immunosuppression
Beta-lactamases and Carbapenemases
PK/PD in Different Patient Populations
Lessons from the Past

Friday 19th June, 2009, 10:15-12:15
HIV: New Agents and Emerging Therapeutic Approaches
The Importance of Antimicrobial Use in the Control of Resistance
Asian Guidelines on Meningitis
Clinical Microbiology (Abstract Symposium)
Public Health Abstract Symposium)

Friday 19th June, 2009, 12:45-14:45
Bad Bugs, Some Drugs: Resistance Trends, New Antimicrobial Strategies and Stewardship
The Evidence for Combination Antifungal Therapy – Wishful Thinking vs. Prudent Practice

Friday 19th June, 2009, 15:00-17:00
Childhood Vaccines: Science Meeting the Challenges of Prevention
Regional and Global Challenges in Infection Control
A Brave New World for Diagnostics: Multiple Pathogens and New Pathogen Detection
Virology I (Abstract Symposium)
Infection Control I (Abstract Symposium)

Friday 19th June, 2009, 17:15-18:15 (Plenary Session)
Invasive Bacterial Disease, Seasonality and Climate Change
Climate Change and Implications for Waterborne Disease in Canada and Abroad

Friday 19th June, 2009, 18:15-18:45 (AMMI Canada Award Session)

Saturday 20th June, 2009, 07:15-08:15 (Meet the Experts)
Tackling Antimicrobial Resistance
Past, present and future risk of infections and possible threats for bioterrorism
Collateral Effects of Antibiotics
Outpatient Management of Febrile Neutropenia: Risk Stratification and New Models of Care
Immigrant and Refugee Health

Saturday 20th June, 2009, 08:30-10:00
Reduced Glycopeptide Susceptibility
Update in Viral Vaccines
Endocarditis Update 2009
Infectious Diseases and Catastrophes
Zoonoses and Tropical Medicine

Saturday 20th June, 2009, 10:15-12:15
Viral Infections in Transplantation: What's Hot?
Public Health Policies and Antimicrobial Resistance
Perspectives on Macrolides
Antimicrobials (Abstract Symposium)
Tropical Diseases/Mycology (Abstract Symposium)

Saturday 20th June, 2009, 12:45-14:45
Fungal Infection in Patients with Hematological Malignancies
Alternative Strategies in the Battle of Gram Negative Bugs

Saturday 20th June, 2009, 15:00-17:00
Towards Better Diagnosis and Treatment of Encephalitis and Meningitis
Antifungal Agent Update
Antimicrobial Resistance in Anaerobic Infections
Tuberculosis (Abstract Symposium)
Virology II (Abstract Symposium)

Saturday 20th June, 2009, 17:15-18:15 (Pleanray Session)
Challenges in Forecasting Patterns of Zoonotic Disease in Response to Climate Change
Sustaining Life on Earth: Infectious Diseases and Eco-Epidemiology

Sunday 21st June, 2009, 08:30-10:00
Short Course Therapy - Is Shorter Better?
Small Babies…Big Diseases: The Silent Saga of Congenital Infections
Clostridium difficile: The Lessons We've Learned and the Challenges to Come
What's New With Sexually Transmitted Infections?
ISC Award Session with HUMA Lecture: Think globally; Act Globally.

Sunday 21st June, 2009, 10:15-12:15
Use and Misuse of Antibiotics in Latin America: Consumption, Resistance and Solutions
Current Topics in Virology
Return of the Syphilis Plague: New Tests, Pregnancy and Congenital Syphilis
Basic and Applied Science (Abstract Symposium)
Infection Control II / Clinical ID (Abstract symposium)

Sunday 21st June, 2009, 12:30-14:30 (Closing Session)

Aktuelles
Maßnahmen zur Umsetzung der neuen Bedeutung von I veröffentlicht
Das NAK hat nunmehr Empfehlungen zur Vermittlung der Umsetzung der neuen Bedeutung von I veröffentlicht....
vom 07.12.2018

Professor Tobias Welte ist neuer Präsident der PEG
Im Rahmen der 26. Jahrestagung in Wien hat die Mitgliederversammlung der PEG am 5. Oktober 2018 einen neuen Vorstand gewählt.
vom 09.10.2018

Wolfgang-Stille-Preis für Forschergruppe der Charité
Der mit 10.000,- Euro dotierte Wolfgang-Stille-Preis (Wissenschaftspreis) der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) wird in diesem Jahr an eine Arbeitsgruppe der Charité Universitätsmedizin Berlin mit herausragenden Ergebnissen verliehen.
vom 14.09.2018

Antibiotika-Resistenzbestimmung
Das European Committee on Antimicrobial Susceptibility Testing (EUCAST) hat die Kategorien S (bisher "sensibel") und I (bisher "intermediär") zur Bewertung der Ergebnisse von Resistenztestungen neu definiert.
vom 14.09.2018

Zum Tod von Georg Peters
Am 8. August 2018 ist Prof. Dr. med. Georg Peters plötzlich und unerwartet verstorben.
vom 17.08.2018

Die PEG trauert um Professor Georg Peters
Gestern erreichte uns die traurige Nachricht, dass Georg Peters bei einer Bergwanderung tödlich verunglückt ist...
vom 10.08.2018

Datenschutzerklärung
Bitte beachten Sie unsere Datenschutzhinweise....
vom 18.07.2018

Nachricht aus dem Robert Koch-Institut
Die Ständige Impfkommission (STIKO) hat ihre Empfehlung, Jungen zwischen 9 und 14 Jahren gegen HPV zu impfen....
vom 28.06.2018